We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Marsh & McLennan Companies, Inc. (MMC - Free Report) delivered first-quarter 2021 adjusted earnings per share of $1.99, surpassing the Zacks Consensus Estimate by 17.1%. This is owing to a solid contribution from its Risk and Insurance Services as well as Consulting segments. Moreover, the bottom line increased 21.3% from the year-ago quarter.
Marsh & McLennan’s consolidated revenues of $5.1 billion were up 9% year over year. Moreover, the top line beat the Zacks Consensus Estimate by 5.6% on the back of its strong Risk and Insurance Services as well as Consulting segments.
Total operating expenses of $3.7 billion in the first quarter were up 4% year over year due to higher compensation and benefits.
Marsh & McLennan Companies, Inc. Price, Consensus and EPS Surprise
Revenues at this segment were $3.2 billion, up 7% on an underlying basis. Adjusted operating income improved 17% to $1.1 billion from the prior-year quarter’s level.
Marsh, a unit within this segment, generated revenues of $2.3 billion, up 8% on an underlying basis. In the U.S./Canada, underlying revenues rose 9% year over year.
Underlying revenues from international operations rose 6% year over year including an 8% increase of the same in the Asia Pacific, a 6% rise in Latin America and a 6% hike in EMEA.
Revenues from another unit under this segment, Guy Carpenter, were up 7% year over year on an underlying basis in the quarter under review.
Consulting
Revenues were up 3% on an underlying basis to $1.9 billion. Also, adjusted operating income was up 28% to $370 million.
A unit within this segment, Mercer, generated revenues of $1.3 billion, which were flat on an underlying basis. Wealth’s revenues were up 1% on an underlying basis. Health’s revenues were flat year over year while that of Career was up 1% on an underlying basis. Another unit Oliver Wyman Group registered revenues of $585 million, up 11% year over year on an underlying basis.
Financial Update
Marsh & McLennan exited the first quarter with cash and cash equivalents of $1.1 billion, down 46.4% from the level at 2020 end.
Net cash used for operations stood at $408 million, lower than the year-ago quarter’s $638 million.
As of Mar 31, 2021, Marsh & McLennan’s total assets were $32.3 billion, down 2.3% from the figure as of Dec 31, 2020.
Total equity was $9.6 billion, up 3.6% from the level at 2020 end.
Of the insurance industry players that have reported first-quarter results so far, earnings of The Travelers Companies, Inc. (TRV - Free Report) , W.R. Berkley Corporation (WRB - Free Report) and Brown & Brown, Inc. (BRO - Free Report) beat the respective Zacks Consensus Estimate.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential. Today, Download Marijuana Moneymakers FREE >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Marsh & McLennan's (MMC) Q1 Earnings Surpass, Improve Y/Y
Marsh & McLennan Companies, Inc. (MMC - Free Report) delivered first-quarter 2021 adjusted earnings per share of $1.99, surpassing the Zacks Consensus Estimate by 17.1%. This is owing to a solid contribution from its Risk and Insurance Services as well as Consulting segments. Moreover, the bottom line increased 21.3% from the year-ago quarter.
Marsh & McLennan’s consolidated revenues of $5.1 billion were up 9% year over year. Moreover, the top line beat the Zacks Consensus Estimate by 5.6% on the back of its strong Risk and Insurance Services as well as Consulting segments.
Total operating expenses of $3.7 billion in the first quarter were up 4% year over year due to higher compensation and benefits.
Marsh & McLennan Companies, Inc. Price, Consensus and EPS Surprise
Marsh & McLennan Companies, Inc. price-consensus-eps-surprise-chart | Marsh & McLennan Companies, Inc. Quote
Quarterly Segmental Results
Risk and Insurance Services
Revenues at this segment were $3.2 billion, up 7% on an underlying basis. Adjusted operating income improved 17% to $1.1 billion from the prior-year quarter’s level.
Marsh, a unit within this segment, generated revenues of $2.3 billion, up 8% on an underlying basis. In the U.S./Canada, underlying revenues rose 9% year over year.
Underlying revenues from international operations rose 6% year over year including an 8% increase of the same in the Asia Pacific, a 6% rise in Latin America and a 6% hike in EMEA.
Revenues from another unit under this segment, Guy Carpenter, were up 7% year over year on an underlying basis in the quarter under review.
Consulting
Revenues were up 3% on an underlying basis to $1.9 billion. Also, adjusted operating income was up 28% to $370 million.
A unit within this segment, Mercer, generated revenues of $1.3 billion, which were flat on an underlying basis. Wealth’s revenues were up 1% on an underlying basis. Health’s revenues were flat year over year while that of Career was up 1% on an underlying basis. Another unit Oliver Wyman Group registered revenues of $585 million, up 11% year over year on an underlying basis.
Financial Update
Marsh & McLennan exited the first quarter with cash and cash equivalents of $1.1 billion, down 46.4% from the level at 2020 end.
Net cash used for operations stood at $408 million, lower than the year-ago quarter’s $638 million.
As of Mar 31, 2021, Marsh & McLennan’s total assets were $32.3 billion, down 2.3% from the figure as of Dec 31, 2020.
Total equity was $9.6 billion, up 3.6% from the level at 2020 end.
Zacks Rank and Performance of Other Players
Marsh & McLennan carries a Zacks Rank #2 (Buy), currently. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Of the insurance industry players that have reported first-quarter results so far, earnings of The Travelers Companies, Inc. (TRV - Free Report) , W.R. Berkley Corporation (WRB - Free Report) and Brown & Brown, Inc. (BRO - Free Report) beat the respective Zacks Consensus Estimate.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>